Shannon Doerhoff
Researcher
Also affiliated: Neurology, Inc (2021)
Unknown Researcher
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Shannon Doerhoff's research focuses on the gait and non-motor characteristics of Parkinson's disease, particularly in relation to medication effects and disease progression. Her work has investigated freezing of gait (FOG), a common and debilitating symptom. Specific studies have examined the phenotype associated with levodopa ONOFF-state FOG, as well as levodopa unresponsive FOG, aiming to define the associated gait and non-motor features. Doerhoff has also explored therapeutic interventions, including a delayed-start trial of modafinil for FOG in Parkinson's disease. Her research is supported by collaborations with colleagues at the University of Arkansas for Medical Sciences, including Aliyah Glover and Tuhin Virmani, with whom she has co-authored multiple publications. Doerhoff has published six total publications, accumulating 111 citations, and holds an h-index of 4.
Metrics
- h-index: 4
- Publications: 6
- Citations: 114
Selected Publications
-
Lessons Learned From a Delayed‐Start Trial of Modafinil for Freezing of Gait in Parkinson's Disease (2025)
-
Levodopa ONOFF-state freezing of gait: Defining the gait and non-motor phenotype (2022)
-
Differential Gait Decline in Parkinson’s Disease Enhances Discrimination of Gait Freezers from Non-Freezers (2020)
-
Impaired step‐length setting prior to turning in Parkinson's disease patients with freezing of gait (2018)
-
Increased foot strike variability in Parkinson's disease patients with freezing of gait (2018)
Collaboration Network
Top Collaborators
- Levodopa ONOFF-state freezing of gait: Defining the gait and non-motor phenotype
- Lessons Learned From a Delayed‐Start Trial of Modafinil for Freezing of Gait in Parkinson's Disease
- Levodopa ONOFF-state freezing of gait: Defining the gait and non-motor phenotype
- Lessons Learned From a Delayed‐Start Trial of Modafinil for Freezing of Gait in Parkinson's Disease
- Levodopa ONOFF-state freezing of gait: Defining the gait and non-motor phenotype
- Lessons Learned From a Delayed‐Start Trial of Modafinil for Freezing of Gait in Parkinson's Disease
- Levodopa ONOFF-state freezing of gait: Defining the gait and non-motor phenotype
- Lessons Learned From a Delayed‐Start Trial of Modafinil for Freezing of Gait in Parkinson's Disease
- Lessons Learned From a Delayed‐Start Trial of Modafinil for Freezing of Gait in Parkinson's Disease
- Lessons Learned From a Delayed‐Start Trial of Modafinil for Freezing of Gait in Parkinson's Disease
- Lessons Learned From a Delayed‐Start Trial of Modafinil for Freezing of Gait in Parkinson's Disease
- Lessons Learned From a Delayed‐Start Trial of Modafinil for Freezing of Gait in Parkinson's Disease
Similar Researchers
Based on overlapping research topics